Emerging Geopolitical Risks to Global Pharmaceutical Supply Chains: A Spotlight on Israel
Heightened regional instability necessitates proactive supply chain diversification and risk mitigation strategies for IBD therapies. Today’s IBD News Highlights The potential for escalated conflict in the Middle East, specifically concerning Israel, presents a growing, if indirect, risk to the global pharmaceutical supply chain, with potential ripple effects for the availability of therapies for inflammatory bowel […]